Po Wang is a Psychiatry physician affiliated with University of California, Irvine. OpenAlex indexes 115 publications with 2,692 citations (h-index 29); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
401 Quarry Rd
Suite 2117
Palo Alto, CA 943041419
Telephone
650-723-8335Provider last certified this registry record 28 Apr 2024.
Clinical trials
- Peri-capsular Nerve Group (PENG) Block and Quadratus Lumborum Block for Hip Arthroplasty
Sponsor: Buddhist Tzu Chi General Hospital
- Video Laryngoscope vs. Video Stylet During General Anesthesia With Obesity Patient
Sponsor: Buddhist Tzu Chi General Hospital
- Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder
Sponsor: Stanford University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Genentech, Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.2%Atypical Antipsychotic31%Quetiapine Fumarate28%Lurasidone Hcl22%Aripiprazole18%Risperidone11%Vraylar9%Olanzapine8%Ziprasidone Hcl5%Part D<11 patientsBenzodiazepine11.3%Clonazepam54%Lorazepam29%Alprazolam17%Part D<11 patients+ 13 more classes in this area
Cardiovascular
1.8%Beta blocker1.8%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Glioma is associated with exposure to legacy and alternative per- and polyfluoroalkyl substances
Journal of Hazardous Materials
2022 - Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorder
Journal of Affective Disorders
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Susan O’Brien, MD
University of California, Irvine
Steven Potkin, MD
University of California, Irvine
Stefan Ciurea, MD
University of California, Irvine
Farshid Dayyani, MD
University of California, Irvine
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”